The Valley Desk

NCT04023110 · Interventional trial

Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab

Overall registry status Completed

Phase 1

Conditions Breast Cancer, Cardiomyopathies, Cardiotoxicity, Heart Failure, Risk Factor, Cardiovascular, Toxicity Due to Chemotherapy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov